OMIC(Delisted)
Singular Genomics·NASDAQ
--
--(--)
Singular Genomics (OMIC) Financials Overview
Singular Genomics (OMIC) released its earnings on Aug 3, 2021: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Aug 3, 2021
EPS
Revenue
Revenue & Expenses
OMIC has released its 2024 Q3 earnings report, with revenue of 406.00K, reflecting a YoY change of -12.12%, and net profit of -16.80M, showing a YoY change of 24.89%. The Sankey diagram below clearly presents OMIC's revenue sources and cost distribution.
Key Indicators
Singular Genomics (OMIC) key financial stats and ratios, covering profitability, financial health, and leverage.
Singular Genomics (OMIC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Singular Genomics (OMIC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Singular Genomics (OMIC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Singular Genomics (OMIC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Singular Genomics (OMIC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
More Financial Metrics
You can ask Aime
No Data
